RATIONALE: Inflammation and thrombosis are related via interactions between leukocytes, platelets, the vasculature, and the coagulation system. However, the mechanisms behind these interactions remain poorly understood. OBJECTIVES: We have investigated the effects of the well known pulmonary inflammation induced by silica for the development of peripheral thrombogenicity in a hamster model of thrombosis. In addition, the consequences of pulmonary macrophage and circulating monocyte and neutrophil depletion on the thrombogenicity were investigated. METHODS: Silica particles (2-200 mug/hamster) were intratracheally instilled, and experimental thrombosis in photochemically induced femoral vein lesions was assessed 24 hours later, in association with cellular infiltration in the lung. MEASUREMENTS AND MAIN RESULTS: Intratracheally instilled silica particles (20 and 200 mug/hamster) triggered pulmonary inflammation, together with stimulation of peripheral platelet-rich thrombus formation. Both the selective depletion of lung macrophages by intratracheal administration of clodronate liposomes and the combined depletion of circulating monocytes and neutrophils by intraperitoneal injection of cyclophosphamide significantly reduced silica-induced influx of macrophages and neutrophils in bronchoalveolar lavage, and reduced peripheral thrombogenicity. Silica-induced lung inflammation was accompanied by increased neutrophil elastase levels in bronchoalveolar lavage and in plasma. Specific neutrophil elastase inhibition in the lung did not affect lung inflammation but reduced peripheral thrombogenicity. CONCLUSION: These findings uncover pulmonary macrophage-neutrophil cross-talk releasing neutrophil elastase into the blood circulation. Elastase, triggering activation of circulating platelets, may then predispose platelets to initiate thrombotic events on mildly damaged vasculature.
RATIONALE: Inflammation and thrombosis are related via interactions between leukocytes, platelets, the vasculature, and the coagulation system. However, the mechanisms behind these interactions remain poorly understood. OBJECTIVES: We have investigated the effects of the well known pulmonary inflammation induced by silica for the development of peripheral thrombogenicity in a hamster model of thrombosis. In addition, the consequences of pulmonary macrophage and circulating monocyte and neutrophil depletion on the thrombogenicity were investigated. METHODS:Silica particles (2-200 mug/hamster) were intratracheally instilled, and experimental thrombosis in photochemically induced femoral vein lesions was assessed 24 hours later, in association with cellular infiltration in the lung. MEASUREMENTS AND MAIN RESULTS: Intratracheally instilled silica particles (20 and 200 mug/hamster) triggered pulmonary inflammation, together with stimulation of peripheral platelet-rich thrombus formation. Both the selective depletion of lung macrophages by intratracheal administration of clodronate liposomes and the combined depletion of circulating monocytes and neutrophils by intraperitoneal injection of cyclophosphamide significantly reduced silica-induced influx of macrophages and neutrophils in bronchoalveolar lavage, and reduced peripheral thrombogenicity. Silica-induced lung inflammation was accompanied by increased neutrophil elastase levels in bronchoalveolar lavage and in plasma. Specific neutrophil elastase inhibition in the lung did not affect lung inflammation but reduced peripheral thrombogenicity. CONCLUSION: These findings uncover pulmonary macrophage-neutrophil cross-talk releasing neutrophil elastase into the blood circulation. Elastase, triggering activation of circulating platelets, may then predispose platelets to initiate thrombotic events on mildly damaged vasculature.
Authors: Dag G Ellingsen; Maxim Chashchin; Ingebjørg Seljeflot; Balazs Berlinger; Valery Chashchin; Leo Stockfelt; Yngvar Thomassen Journal: Int Arch Occup Environ Health Date: 2019-05-21 Impact factor: 3.015
Authors: Gökhan M Mutlu; David Green; Amy Bellmeyer; Christina M Baker; Zach Burgess; Nalini Rajamannan; John W Christman; Nancy Foiles; David W Kamp; Andrew J Ghio; Navdeep S Chandel; David A Dean; Jacob I Sznajder; G R Scott Budinger Journal: J Clin Invest Date: 2007-10 Impact factor: 14.808
Authors: Jeff G Leid; Mathias Kerr; Candice Selgado; Chelsa Johnson; Gabriel Moreno; Alyssa Smith; Mark E Shirtliff; George A O'Toole; Emily K Cope Journal: Infect Immun Date: 2009-08-03 Impact factor: 3.441
Authors: Maria Jose Santos-Martinez; Iwona Inkielewicz-Stepniak; Carlos Medina; Kamil Rahme; Deirdre M D'Arcy; Daniel Fox; Justin D Holmes; Hongzhou Zhang; Marek Witold Radomski Journal: Int J Nanomedicine Date: 2012-01-13
Authors: Swapna Upadhyay; Tobias Stoeger; Volkar Harder; Ronald F Thomas; Mette C Schladweiler; Manuela Semmler-Behnke; Shinji Takenaka; Erwin Karg; Peter Reitmeir; Michael Bader; Andreas Stampfl; Urmila P Kodavanti; Holger Schulz Journal: Part Fibre Toxicol Date: 2008-12-04 Impact factor: 9.400